Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20190210042676N33
IRCT20190210042676N33
Recruiting
Phase 2

Clinical study to evaluate the safety and efficacy of Lunagel 2.5 dermal filler (Nikan Teb Kimia CO) for correction of moderate to severe nasolabial fold

ikan Teb Kimia CO0 sites30 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
ikan Teb Kimia CO
Enrollment
30
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
ikan Teb Kimia CO

Eligibility Criteria

Inclusion Criteria

  • •18 \-65 years old men and women
  • •Moderate to severe nasolabial folds based on Allergan criteria.
  • •The opportunity to accompany the visit programs and study process
  • •Signing the informed consent form and agree to a 6\-month follow\-up.

Exclusion Criteria

  • •Cosmetic facial procedures (chemical peel, laser, radio frequency, dermabrasion, ablative or non\-ablative procedures), Botox) in the lower 2/3 of the face, within 3 months prior to study entry
  • •Previous hyaluronic acid (HA)\-based dermal filler treatment(s) injected within the last 12 months prior to enrollment.
  • •Planning to undergo any of these procedures at any time during the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 2
Clinical study to evaluate the safety and efficacy of cinnamon in the management of non-alcoholic fatty liver diseaseHealth Condition 1: K760- Fatty (change of) liver, not elsewhere classified
CTRI/2021/03/032039Central council for research in Unani medicine New dehli60
Completed
Not Applicable
To study the effect of Tab HFO-O2 in fatty individuals.
CTRI/2016/07/007067Baidyanath Bhavan Pvt Ltd
Active, not recruiting
Phase 3
A Clinical Study to Evaluate the Safety and Efficacy of Livercure Tablets on Patients with Liver Cirrhosis.Health Condition 1: K745- Biliary cirrhosis, unspecifiedHealth Condition 2: K745- Biliary cirrhosis, unspecified
CTRI/2022/07/043725Jammi Pharmaceuticals Pvt Ltd
Completed
Phase 2
A study for Under eye dark circles
CTRI/2022/09/045732Transformative Learning Solutions Pvt Ltd32
Active, not recruiting
Not Applicable
Clinical study to evaluate the efficacy and safety of Octagam® 10% in Idiopathic Thrombocytopenic Purpura in adults. - N/A
EUCTR2005-003552-35-DEOctapharma AG116